Atlas Trials

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Clinical trial NCT02053350 · TERMINATED

Trial details

NCT number
NCT02053350
Sponsor
University of Virginia
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile Infection
Start date
2015-04-01
Primary completion
2017-04-05
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.